Literature DB >> 1923937

Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor.

R E Carraway1, S P Mitra, C Paradise.   

Abstract

Processing of the precursor to neurotensin/neuromedin-N was studied in brain and intestine from four mammalian species (dog, cat, guinea pig and rat) using previously characterized immunoassays for neurotensin and neuromedin-N, as well as newly developed assays towards the 35-44 sequence (P1) and the 70-85 sequence (P2) of the canine precursor. While neurotensin was the major product (approximately 98%) with neurotensin immunoreactivity in brain and ileum, a large molecular form of neuromedin-N was found to comprise 55-91% of the neuromedin-N activity in the ileum of these species and only 2-8% that in brain. Large neuromedin-N, which behaved as a single substance during multiple chromatographic steps, was found to cross-react in the assays for P1 and P2, indicating that this molecule extended at least from residues 40-148, neuromedin-N being located at its C-terminus. Western blots confirmed the results obtained by immunoassay. Partially purified preparations of large neuromedin-N from dog, cat and rat were also found to contract the isolated guinea pig ileum, exhibiting potencies near to that of neuromedin-N. These results indicate that tissue-specific storage of large neuromedin-N, a biologically active molecule with greater than 100 amino acids, occurs in these four mammals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923937     DOI: 10.1016/0196-9781(91)90108-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

2.  Role of proneurotensin as marker of paediatric coeliac disease.

Authors:  C Montén; Å Torinsson Naluai; D Agardh
Journal:  Clin Exp Immunol       Date:  2016-10-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.